AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Cramer's Morning Take: Eli Lilly & Bristol Myers 12/4/24
Squawk on the Street
Intro
This chapter explores the promising results of Eli Lilly's drug ZepBow in a phase three trial, which showed a significantly higher average weight loss compared to Nordisk's Wigobi. The findings suggest ZepBow may redefine expectations in the weight loss treatment market.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode